TMCnet News

angelMD Announces Partnership with Denver's Catalyst HTI
[January 12, 2017]

angelMD Announces Partnership with Denver's Catalyst HTI


SEATTLE, Jan. 12, 2017 /PRNewswire/ -- Health care focused crowd-funding platform, angelMD, announced today a new partnership with Denver-based startup hub, Catalyst Health Tech Innovation (Catalyst HTI).  The partnership includes a dedicated space in Catalyst HTI's new complex, which is currently under construction and is expected to bring together innovative ideas and companies from across the medical information technology marketplace. angelMD joins a growing list of leading health and technology companies that have decided to join the exciting ecosystem at Catalyst HTI, including Kaiser Permanente, Hitachi Consulting, Prime Health, Medical Group Management Association (MGMA) and a host of digital health startups.

"We are looking forward to working with Catalyst HTI to accelerate digital health innovation in Denver and across the country," said Tobin Arthur, founder and CEO of angelMD. "Our partnership will be a valuable asset to drive change in how individuals, especially medical professionals, invest in the innovation taking place throughout the health care industry."

As one of the fastest growing technology markets in the US, Denver is also becoming a favored location for many startups from across the United States, including those in health IT. Denver has attracted a new and innovative culture that combines favorable cost of living, availability of talent and a great quality of life. angelMD's goal with this partnership is to tap into the innovation culture and add to the growing tech economy in the 'Mile-High City.' With a rapidly growing health care innovation sector, Denver is the ideal location for angelMD's unique expertise in health tech fundng.



"angelMD will find the Denver community welcoming and engaging," stated Mike Biselli, president of Catalyst HTI." This is the perfect environment for them to thrive, and we are excited to embed their innovative investment marketplace operations within the Catalyst HTI community."

Based in Seattle, angelMD is redefining early stage healthcare investing taking it from a completely analog and amateur endeavor to one that is more digital, informed by data and leverages the strength of its growing network of experts. The platform connects medical startups, physicians, investors and industry with the goal of better outcomes. angelMD enables medical startups to create profiles on their site and develop exposure with potential investors, customers and acquirers.


Located in Denver, Colorado's River North District (RiNo), Catalyst HTI is a 300,000 square-foot industry integrator designed to bring digital health start-ups and established health care entities together under one roof. The building will cover an entire city block and be located on the west side of Brighton Boulevard between 35th and 36th Streets. Catalyst's goal is to bring together private enterprise (startups to Fortune 20), government, academic and non-profit organizations with healthcare providers and payers to accelerate innovation and drive real, lasting change.

The building project is scheduled to be complete in the first quarter of 2018.

About angelMD

angelMD is an investment platform and marketplace connecting innovative medical startups, physicians, investors and industry partners. Leading physicians from all over the US have joined the angelMD Scientific Advisory Board and Leaders Club to help source, evaluate and advise companies in biotechnology, medical device and healthcare technology. For more information, visit www.angelmd.co.

About Catalyst HTI

Catalyst HTI is an industry integrator, bringing together all of the relevant stakeholders in health-tech innovation – from single-person startups and Fortune 500 companies to non-profit organizations and healthcare providers – to build a community where collaboration and integration ultimately lead to accelerated innovation within the industry. Located in Denver, Colorado's burgeoning River North district and developed by Koelbel and Company, phase one of Catalyst HTI is slated to open in Q1 2018. For more information visit  www.catalysthealthtech.com.

CONTACT: 
Kent Sholars (angel MD) or Mike Biselli (Catalyst HTI)  
[email protected] or [email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/angelmd-announces-partnership-with-denvers-catalyst-hti-300389935.html

SOURCE angelMD


[ Back To TMCnet.com's Homepage ]